Profusa, Inc. Common Stock (PFSA) vs Beyond Air, Inc. (XAIR)
A side-by-side comparison of Profusa, Inc. Common Stock and Beyond Air, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PFSA
Profusa, Inc. Common Stock
$1.70HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
XAIR
Beyond Air, Inc.
$2.61HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
Total return — PFSA vs XAIR
growth of $100 · dividends reinvested · last 1yPFSA -100.0% (-100.0%/yr)XAIR -95.9% (-95.9%/yr)XAIR compounded faster over this window
Log scale — wide-divergence pair
PFSA XAIR
PFSA vs XAIR: by the numbers
- •XAIR is the larger company ($2M vs $2M market cap).
- •Both run net losses; PFSA's is the smaller (0.00% vs -435.71% net margin).
Metrics side by side
Valuation
| Metric | PFSA | XAIR |
|---|---|---|
| P/S ratio | N/A | 0.24 |
Profitability
| Metric | PFSA | XAIR |
|---|---|---|
| Gross margin | 0.00% | 4.18% |
| Operating margin | 0.00% | -378.23% |
| Net margin | 0.00% | -435.71% |
| ROE | N/A | -1677.17% |
| ROIC | N/A | -106.06% |
Growth (annualized)
| Metric | PFSA | XAIR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 64.21% |
| Total return CAGR (5Y) | N/A | -76.73% |
Go deeper
Dig into the metrics
Profusa, Inc. Common Stock ROEBeyond Air ROEProfusa, Inc. Common Stock operating marginBeyond Air operating marginProfusa, Inc. Common Stock revenue growthBeyond Air revenue growthProfusa, Inc. Common Stock free cash flowBeyond Air free cash flow
Profusa, Inc. Common Stock & Beyond Air appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.